Metraipolis › archive › dc_b784ffa534e6

Biochemical, Biological, and Clinical Properties of γ-Oryzanol — Europe PMC PMID:41009004

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41009004
DOI
10.3390/antiox14091099
License (as archived)
solo-consultazione
Archived
2026-11-10T01:05:56.154Z
SHA-256 of the archived text
259008c015bef4a64a52f1baed9f74f395ee5e6ee829e56aff7cc1709fe1de12
Stable URL of this page
https://metraipolis.com/documento/dc_b784ffa534e6

How to cite

Biochemical, Biological, and Clinical Properties of γ-Oryzanol — Europe PMC PMID:41009004 — Europe PMC (en), https://europepmc.org/article/MED/41009004 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b784ffa534e6 (Metraipolis archive dc_b784ffa534e6, sha256 259008c015bef4a64a52f1baed9f74f395ee5e6ee829e56aff7cc1709fe1de12)
BibTeX
@misc{dcb784ffa534e6,
  title = {Biochemical, Biological, and Clinical Properties of γ-Oryzanol — Europe PMC PMID:41009004},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41009004},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b784ffa534e6; sha256 259008c015bef4a64a52f1baed9f74f395ee5e6ee829e56aff7cc1709fe1de12},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41009004. Agents can read the archived copy with the MCP tool read_document.